Lv1
40 积分 2022-03-07 加入
Tumour burden and efficacy of immune-checkpoint inhibitors
2小时前
已完结
Clinical implications of T cell exhaustion for cancer immunotherapy
2小时前
已完结
The future of immune checkpoint therapy
2小时前
已完结
Chinses expert consensus on the multidisciplinary team diagnosis and treatment of lung cancer
1个月前
已完结
Bioorthogonal chemistry
1个月前
已完结
A Darwinian perspective on tumor immune evasion
1个月前
已完结
Pembrolizumab plus allogeneic NK cells in advanced non–small cell lung cancer patients
1个月前
已完结
Enhanced preclinical antitumor activity of M7824, a bifunctional fusion protein simultaneously targeting PD-L1 and TGF-β
1个月前
已完结
A Bispecific Dendritic-T cell Engager Induces Potent Antitumor Immunity
1个月前
已完结
Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells
2个月前
已完结
皖公网安备34019202002308
